Isabel D C Markl

Title: Isabel D C Markl: Innovator in Cancer Research

Introduction

Isabel D C Markl is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of cancer research through her innovative work on methylation-altered DNA sequences. Her research focuses on identifying novel markers associated with human cancer, which can aid in diagnosis and treatment.

Latest Patents

Isabel D C Markl holds a patent for "Methylation altered DNA sequences as markers associated with human cancer." This patent discloses 103 novel methylation-altered DNA sequences, referred to as 'marker sequences,' that exhibit distinct methylation patterns in cancer compared to normal tissue. Many of these sequences are unique and not found in the GenBank database. They have not been previously characterized concerning their methylation patterns in human cancers, including bladder and prostate cancers. The utility of these sequences lies in their potential as diagnostic, prognostic, and therapeutic markers in cancer treatment, as well as reagents in kits for detecting methylated CpG-containing nucleic acids.

Career Highlights

Isabel D C Markl is affiliated with the University of Southern California, where she continues her research and innovation in the field of cancer. Her work has garnered attention for its potential impact on cancer diagnostics and treatment strategies.

Collaborations

Isabel has collaborated with notable colleagues, including Gangning Liang and Hualin Fu, to advance her research initiatives. These collaborations have contributed to the depth and breadth of her work in cancer research.

Conclusion

Isabel D C Markl is a trailblazer in the field of cancer research, with her innovative patent on methylation-altered DNA sequences paving the way for advancements in cancer diagnostics and treatment. Her contributions are vital to the ongoing fight against cancer, and her work continues to inspire future research in this critical area.